Clinical evaluation and monitoring of the effect of extracorporeal shockwave therapy in sub-acute and chronic post-stroke spasticity patients

Abstract

IntroductionTo evaluate the efficacy and maintenance of extracorporeal shockwave therapy (ESWT) in sub-acute and chronic post-stroke spasticity patients in the Suez Canal region.MethodsAn interrupted time series study was conducted; 82 patients were recruited in accordance with the defined inclusion and exclusion criteria. They were divided into 2 subgroups depending on the stroke duration: a sub-acute group (35 patients) and a chronic group (47 patients). ESWT was applied over knee and ankle flexor muscle belly with the following setup parameters: energy: 0.068–0.093 mJ/mm; frequency: 5 Hz; number of shots: 1500. Modified Ashworth score, clonus score, 3-minute walk test, range of motion angle of both knee and ankle joint, and Fugl-Meyer Assessment were established at baseline, after the 1<sup>st</sup> session, and at the 1<sup>st</sup>, 4<sup>th</sup>, and 8<sup>th</sup> week for the 2 groups.ResultsRegarding the sub-acute group, there was a statistically significant improvement in the modified Ashworth score, clonus score, 3-minute walk test, and range of motion angle of both knee and ankle joint after the 1<sup>st</sup> session and after the 1<sup>st</sup> week of intervention. The differences were not statistically significant after 4<sup>th</sup> or 8<sup>th</sup> week. The chronic group showed no statistically significant improvement after the 1<sup>st</sup> session or in the 1<sup>st</sup>, 4<sup>th</sup>, or 8<sup>th</sup> week assessment.ConclusionsESWT was more effective in treatment of spasticity in patients with sub-acute stroke compared with those with chronic stroke.